DRUG PRESCRIBING PATTERN OF VARIOUS ANTIFUNGAL DRUGS FOR DERMATOPHYTOSIS IN A TERTIARY HEALTHCARE AND TEACHING HOSPITAL

Authors

  • VIRENDRA KUSHWAHA 1 Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India
  • POOJA AGRAWAL Department of Pharmacology, RDW Medical College, Banda, Uttar Pradesh, India
  • NASREEN FATMA KHAN Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India https://orcid.org/0009-0001-2073-2212
  • DEV PRAKASH SHIVHARE Department of Skin and Venereal diseases, GSVM Medical College, Kanpur, Uttar Pradesh, India
  • AMIT KUMAR Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India
  • HIMANSHU SHARMA Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India

DOI:

https://doi.org/10.22159/ijpps.2023v15i4.47457

Keywords:

Drugs, Prescription, Dermatophytosis, Topical, Systemic antifungal

Abstract

Objective: To analyze the pattern of drug prescription and the rationality of pharmacotherapy used in dermatophytosis.

Methods: A prospective observational study was conducted from January 2021 to June 2022 in the Department of Skin and Venereal Diseases. Prescriptions included all newly diagnosed patients with cutaneous fungal infections of both genders who attended Dermatology OPD. Factors considered were sociodemographic parameters, clinical manifestations, combination and monotherapy along with prescribed topical and systemic agents, and details of prescribing indicators.

Results: A total of 362 dermatophytosis cases were observed, which included 230 males and 132 females. Patients in the age group of 13-40 y (65.47%) have shown the dominance of dermatophytosis infection with a high prevalence among the student category, which accounts for 177. Tinea corporis (40.85%) was the prominent clinical manifestation of dermatophytosis infection. Among single topical agents, the most commonly prescribed drug is Clotrimazole (15.19%), and among topical combinations, sertaconazole and ketoconazole (29.28%). Itraconazole (48.75%) is the most commonly used oral formulation, followed by the itraconazole and terbinafine combination (22.56%). While imidazoles were the maximally prescribed topical antifungals according to the therapeutic class.

Conclusion: Tinea corporis is the prominent clinical manifestation and the majority of prescriptions were for a combination of three agents mainly oral itraconazole with topical sertaconazole, and ketoconazole.

Downloads

Download data is not yet available.

References

Joel JJ, Jose N, Shastry CS. Patterns of skin disease and prescribing trends in rural India. Sch Acad J Pharmacol. 2013;2(4):304-9.

Parvathy G, Sudha MJ, Pillai RT, Ramani PT. A study on the prescription pattern of antifungal drugs in the dermatology department of a tertiary care teaching hospital in Southern Kerala. Int J Basic Clin Pharmacol. 2019;8:100-3.

Grover S, Ranyal RK, Bedi MK. A cross-section of skin diseases in rural Allahabad. Indian J Dermatol. 2008;53(4):179-81. doi: 10.4103/0019-5154.44789, PMID 19882029.

Saravanakumar RT, Prasad GS, Ragul G, Mohanta GP, Manna PK, Moorthi C. Study of prescribing pattern of topical corticosteroids in the department of dermatology in a multi-specialty tertiary care teaching hospital in south India. Int J Res Pharm Sci. 2012;3(4):685-7.

Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R, Taskforce on Onychomycosis Education. Treatment options development of consensus guidelines. J Eur Acad Dermatol Venereol. 2005;19Suppl 1:25-33. doi: 10.1111/j.1468-3083.2005.01284.x, PMID 16120203.

Gupta AK, Chow M, Daniel CR, Aly R. Treatments of tinea pedis. Dermatol Clin. 2003;21(3):431-62. doi: 10.1016/s0733-8635(03)00032-9, PMID 12956197.

Nozickova M, Koudelkova V, Kulikova Z, Malina L, Urbanowski S, Silny W. A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis. Int J Dermatol. 1998;37(9):703-5. doi: 10.1046/j.1365-4362.1998.00541.x, PMID 9762826.

Sharma R, Khajuria R, Sharma P, Sadhotra P, Kapoor B, Kohli K. Glaucoma therapy: prescribing pattern and cost analysis. JK Sci. 2004;6(2):88-92.

Phillips I. Prudent use of antibiotics: are our expectations justified? Clin Infect Dis. 2001;33(3)Suppl 3:S130-2. doi: 10.1086/321838, PMID 11524709.

Ellis D, Watson A. Systemic antifungal agents for cutaneous fungal infections. Aust Prescr. 1996;19(3):72-5. doi: 10.18773/austprescr.1996.067.

Korting HC, Schöllmann C. The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes. J Dtsch Dermatol Ges. 2009;7(1):11-20. doi: 10.1111/j.1610-0387.2008.06751.x, PMID 18479501.

Tikoo D, Chopra SH, Kaushal S, Dogra S. Evaluation of drug use pattern in dermatology as a tool to promote rational prescribing. J of Med Educ Res. 2011;13:128-31.

Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991;99(4):837-41. doi: 10.1378/chest.99.4.837, PMID 2009784.

Vegada BN, Kareli BN, Singh AP. Drug utilization study of antifungal agents used in the department of skin and venereal disease of a tertiary care teaching hospital. Int J Pharm Sci Rev Res. 2015;34(1):118-21.

Rao C, Rao R. A cross-sectional study of dermatological problems among differently-abled children. Indian J Dermatol. 2012;57(1):35-7. doi: 10.4103/0019-5154.92674, PMID 22470206.

Al-jabri MM, Shastry CS, Chand S. Assessment of drug utilization pattern in chronic kidney disease patients in a tertiary care hospital based on WHO core drug use indicators. J Glob Pharm Technol. 2019;11(09):1-9.

Boddepalli D. Prescription pattern of commonly used drugs in dermatology OPD at tertiary care hospital. Indian J Res. 2019;8(9).

Pathak AK, Kumar S, Kumar M, Mohan L, Dikshit H. Study of drug utilization pattern for skin diseases in dermatology OPD of an Indian tertiary care hospital–a prescription survey. J Clin Diagn Res. 2016 Feb;10(2):FC01-5. doi: 10.7860/JCDR/2016/17209.7270, PMID 27042479.

Kaur R, Panda PS, Sardana K, Khan S. Mycological pattern of dermatomycoses in a tertiary Care Hospital. J Trop Med. 2015;2015:157828. doi: 10.1155/2015/157828, PMID 26491453.

Poluri LV, Indugula JP, Kondapaneni SL. Clinicomycological study of dermatophytosis in South India. J Lab Physicians. 2015;7(2):84-9. doi: 10.4103/0974-2727.163135, PMID 26417157.

Hanumanthappa H, Sarojini K, Shilpashree P, Muddapur SB. Clinicomycological study of 150 cases of dermatophytosis in a tertiary care hospital in South India. Indian J Dermatol. 2012;57(4):322-3. doi: 10.4103/0019-5154.97684, PMID 22837576.

Agarwal US, Saran J, Agarwal P. Clinico-mycological study of dermatophytes in a tertiary care centre in Northwest India. Indian J Dermatol Venereol Leprol. 2014 Mar-Apr;80(2):194. doi: 10.4103/0378-6323.129434, PMID 24685877.

Patro N, Panda M, Jena AK. The menace of superficial dermatophytosis on the quality of life of patients attending referral hospital in Eastern India: a cross-sectional observational study. Indian Dermatol Online J. 2019;10(3):262-6. doi: 10.4103/idoj.IDOJ_342_18, PMID 31149568.

Noronha TM, Tophakhane RS, Nadiger S. Clinico-microbiological study of dermatophytosis in a tertiary-care hospital in North Karnataka. Indian Dermatol Online J. 2016;7(4):264-71. doi: 10.4103/2229-5178.185488, PMID 27559499.

Naglot A, Shrimali DD, Nath KB, Gogoi KH, Veer V, Chander J. Recent trends of dermatophytosis in Northeast India (Assam) and interpretation with published studies. Int J Microbiol Appl Sci. 2015;4:111-20.

Vegada BN, Karelia BN, Singh AP. Drug utilization study of antifungal agents used in the department of skin and v.d. of a tertiary care teaching hospital. Int J Pharm Sci Rev Res. 2015;34(1):118-21.

Koshley V, Halwai A, Koshley S, Kurrey P, Jaiswal S. Treatment pattern of dermatophytosis at the outpatient clinic of a tertiary healthcare hospital of Chhattisgarh, Central India. Indian J Clin Exp Dermatol. 2018;4(4):327-30.

Kamerkar AS. Prescription pattern and the cost analysis of tinea and acne patients in the dermatology department of a tertiary care teaching hospital. RA Journal of Applied Research. 2016;2:416-23.

Al Balushi KA, Alzaabi MA, Alghafri F. Prescribing pattern of antifungal medications at a tertiary care hospital in Oman. J Clin Diagn Res. 2016;10(12):FC27-30. doi: 10.7860/JCDR/2016/23591.9005, PMID 28208876.

Deb P, Mohanty I, Slathia I, Verma V. Drug utilisation and self-medication pattern of anti-fungal drugs in dermatology outpatient department of a tertiary care hospital. Int J Basic Clin Pharmacol. 2017;6(9):2189-92. doi: 10.18203/2319-2003.ijbcp20173742.

Published

01-04-2023

How to Cite

KUSHWAHA, V., P. AGRAWAL, N. FATMA KHAN, D. P. SHIVHARE, A. KUMAR, and H. SHARMA. “DRUG PRESCRIBING PATTERN OF VARIOUS ANTIFUNGAL DRUGS FOR DERMATOPHYTOSIS IN A TERTIARY HEALTHCARE AND TEACHING HOSPITAL”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 15, no. 4, Apr. 2023, pp. 16-21, doi:10.22159/ijpps.2023v15i4.47457.

Issue

Section

Original Article(s)